Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 135Small Cell Lung Carcinoma 51Lung Neoplasms 45Melanoma 15Carcinoma, Renal Cell 14Carcinoma, Transitional Cell 10Stomach Neoplasms 9Neoplasms 9Head and Neck Neoplasms 9Carcinoma, Hepatocellular 9Mesothelioma, Malignant 8Colorectal Neoplasms 8Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Breast Neoplasms 6Uterine Cervical Neoplasms 5Neoplasm Metastasis 5Kidney Neoplasms 5Carcinoma, Merkel Cell 5Thoracic Neoplasms 4Carcinoma, Neuroendocrine 4Small Cell Lung Cancer Extensive Stage 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Mesothelioma 3Lung Diseases 3Gastrointestinal Neoplasms 3Esophageal Neoplasms 3Brain Neoplasms 3

Interventions

Cisplatin 6Etoposide 5Topotecan 4Carboplatin 4Pemetrexed 3Gemcitabine 3belinostat 2Temozolomide 2RRx-001 2vosaroxin 1vinflunine 1veliparib 1taxane 1sagopilone 1sacituzumab govitecan 1pembrolizumab 1lurtotecan 1liposomal doxorubicin 1enzalutamide 1bemiparin 1belotecan 1atezolizumab 1apalutamide 1alvocidib 1abiraterone 1Vinorelbine 1Tomography, X-Ray Computed 1Sorafenib 1Rhenium 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Small Cell × atezolizumab × Thoracic × Clear all
NCT07625644 2026-06-04

Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer

SystImmune Inc.

Phase 3 Not yet recruiting
550 enrolled
Thoracic

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡